These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12889218)

  • 1. Assessment of heart involvement.
    Ferri C; Emdin M; Nielsen H; Bruhlmann P
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S24-8. PubMed ID: 12889218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart involvement and systemic sclerosis.
    Ferri C; Giuggioli D; Sebastiani M; Colaci M; Emdin M
    Lupus; 2005; 14(9):702-7. PubMed ID: 16218471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
    In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heart involvement and pulmonary arterial hypertension in patients with systemic sclerosis].
    Cikes N
    Reumatizam; 2010; 57(2):99-104. PubMed ID: 21875012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography.
    Rodríguez-Reyna TS; Morelos-Guzman M; Hernández-Reyes P; Montero-Duarte K; Martínez-Reyes C; Reyes-Utrera C; Vazquez-La Madrid J; Morales-Blanhir J; Núñez-Álvarez C; Cabiedes-Contreras J
    Rheumatology (Oxford); 2015 Apr; 54(4):647-54. PubMed ID: 25239881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of scleroderma in a New Zealand tertiary rheumatology centre: emphasis on pulmonary complications.
    Ng K; Gow P
    N Z Med J; 2007 May; 120(1254):U2537. PubMed ID: 17515941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report).
    Foocharoen C; Pussadhamma B; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Rheumatology (Oxford); 2015 Sep; 54(9):1616-21. PubMed ID: 25863044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies.
    Meune C; Vignaux O; Kahan A; Allanore Y
    Arch Cardiovasc Dis; 2010 Jan; 103(1):46-52. PubMed ID: 20142120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of asymmetric dimethylarginine and cardiac involvement in systemıc sclerosis.
    Dağ Ş; Budulgan M; Dilek B; Batmaz I; Arıtürk Z; Nas K; Çevik R
    Acta Reumatol Port; 2014; 39(3):228-35. PubMed ID: 25326403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome measures for heart involvement in systemic sclerosis.
    Allanore Y; Meune C; Kahan A
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v51-3. PubMed ID: 18784146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic sclerosis and cardiac dysfunction: evolving concepts and diagnostic methodologies.
    Allanore Y; Meune C; Kahan A
    Curr Opin Rheumatol; 2008 Nov; 20(6):697-702. PubMed ID: 18946331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive assessment of myocardial involvement in patients with systemic sclerosis: role of signal averaged electrocardiography.
    Morelli S; Sgreccia A; De Marzio P; Perrone C; Ferrante L; Gurgo AM; Gurgo di Castelmenardo AM; Aguglia G; De Vincentiis G; Scopinaro F; Calvieri S
    J Rheumatol; 1997 Dec; 24(12):2358-63. PubMed ID: 9415642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart disease in systemic sclerosis.
    Janosik DL; Osborn TG; Moore TL; Shah DG; Kenney RG; Zuckner J
    Semin Arthritis Rheum; 1989 Dec; 19(3):191-200. PubMed ID: 2690346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of kidney involvement.
    Steen VD; Mayes MD; Merkel PA
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S29-31. PubMed ID: 12889219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients.
    Chighizola C; Meroni PL; Schreiber BE; Coghlan JG; Denton CP; Ong VH
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S81-5. PubMed ID: 22691215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic sclerosis and the heart.
    Parks JL; Taylor MH; Parks LP; Silver RM
    Rheum Dis Clin North Am; 2014 Feb; 40(1):87-102. PubMed ID: 24268011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.
    Hung G; Mercurio V; Hsu S; Mathai SC; Shah AA; Mukherjee M
    Curr Rheumatol Rep; 2019 Dec; 21(12):68. PubMed ID: 31813082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Involvement in Systemic Sclerosis: Diagnostic Tools and Evaluation Methods.
    Smolenska Z; Barraclough R; Dorniak K; Szarmach A; Zdrojewski Z
    Cardiol Rev; 2019; 27(2):73-79. PubMed ID: 29994849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal.
    Spinella A; Coppi F; Mattioli AV; Lumetti F; Rossi R; Cocchiara E; Colaci M; Boriani G; Ferri C; Salvarani C; Giuggioli D
    J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):513-515. PubMed ID: 30004950
    [No Abstract]   [Full Text] [Related]  

  • 20. Manual of signs, symptoms, methods and procedures for the assessment of the patient with SSc.
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S49-56. PubMed ID: 12889224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.